Exelixis Inc (NASDAQ:EXEL)

19.56
Delayed Data
As of Sep 20
 -0.01 / -0.05%
Today’s Change
13.42
Today|||52-Week Range
25.31
-0.56%
Year-to-Date

Today’s Trading

Previous close19.57
Today’s open19.64
Day’s range19.46 - 20.04
Volume5,068,007
Average volume (3 months)2,561,828
Market cap$5.9B
Data as of 4:00pm ET, 09/20/2019

Growth & Valuation

Earnings growth (last year)+345.48%
Earnings growth (this year)-59.58%
Earnings growth (next 5 years)+46.00%
Revenue growth (last year)+86.83%
P/E ratio9.5
Price/Sales7.28
Price/Book4.56

Competitors

 Today’s
change
Today’s
% change
AMRNAmarin Corporation P...-0.10-0.59%
SYNHSyneos Health Inc-0.18-0.33%
CRLCharles River Labora...+0.68+0.49%
ADPTAdaptive Biotechnolo...+1.18+3.02%
Data as of 6:30pm ET, 09/20/2019

Financials

Next reporting dateNovember 1, 2019
EPS forecast (this quarter)$0.19
Annual revenue (last year)$845.7M
Annual profit (last year)$690.1M
Net profit margin81.59%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael M. Morrissey
Chief Financial &
Accounting Officer, Executive VP
Christopher J. Senner
Corporate headquarters
Parkway Alameda, California

Forecasts